Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
This study evaluates the use of statins for primary prevention of cardiovascular diseases in adults aged 75 years and older, demonstrating a significant reduction in CVD incidence without an increase in severe adverse events. These findings provide real-world evidence to guide clinical decision-making in this underrepresented population.
Cardiology June 5th 2024
Epoch Health
The FDA has recalled Abbott’s HeartMate 3 LVAD after reports of severe complications during implantation, including blood leakage and air entry, which can lead to serious surgical risks.
Statins, although effective at lowering cholesterol, may inadvertently impair immune function by reducing vitamin D synthesis. This opinion piece examines how this could have influenced COVID-19 outcomes, highlighting critical considerations for clinical practice.
The New England Journal of Medicine
Prehospital management of blood pressure in patients with suspected acute stroke shows varying impacts depending on the stroke type. Immediate reduction improves outcomes in hemorrhagic stroke but may worsen outcomes in ischemic stroke, emphasizing the need for tailored approaches in early stroke care.
Cardiology June 4th 2024
Healthgrades for Professionals
New research suggests a link between frequent daytime napping and an increased risk of hypertension and stroke, highlighting the importance of evaluating patients’ sleep habits as part of their cardiovascular risk assessment.
The phase 3 trial of aficamten for symptomatic obstructive hypertrophic cardiomyopathy showed a significant improvement in peak oxygen uptake compared to placebo, with meaningful enhancements in patient-reported outcomes and clinical measures.
Cardiology May 22nd 2024